Travere Therapeutics, Inc. (TVTX)
45.02
-2.16
(-4.59%)
USD |
NASDAQ |
Jun 01, 16:00
45.04
+0.02
(+0.06%)
After-Hours: 20:00
Travere Therapeutics EPS Diluted (Quarterly) : -0.3984 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.3861 |
| Mirum Pharmaceuticals, Inc. | -13.43 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Insmed, Inc. | -0.7591 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.60M |
| Revenue (Quarterly) | 127.20M |
| Total Expenses (Quarterly) | 163.80M |
| Enterprise Value | 4.450B |
| Gross Profit Margin (Quarterly) | 78.65% |
| Profit Margin (Quarterly) | -28.78% |
| Earnings Yield | -1.19% |
| Normalized Earnings Yield | -1.188 |